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Abstract 
Background: Previous studies have indicated that selenium supplementation may be beneficial in neuroprotec‑
tion against glutamate‑induced cell damage, in which mitochondrial dysfunction is considered a major pathogenic 
feature. However, the exact mechanisms by which selenium protects against glutamate‑provoked mitochondrial per‑
turbation remain ambiguous. In this study glutamate exposed murine hippocampal neuronal HT22 cell was used as a 
model to investigate the underlying mechanisms of selenium‑dependent protection against mitochondria damage.
Results: We find that glutamate‑induced cytotoxicity was associated with enhancement of superoxide production, 
activation of caspase‑9 and ‑3, increases of mitochondrial fission marker and mitochondrial morphological changes. 
Selenium significantly resolved the glutamate‑induced mitochondria structural damage, alleviated oxidative stress, 
decreased Apaf‑1, caspases‑9 and ‑3 contents, and altered the autophagy process as observed by a decline in the 
ratio of the autophagy markers LC3‑I and LC3‑II.
Conclusion: These findings suggest that the protection of selenium against glutamate stimulated cell damage of 
HT22 cells is associated with amelioration of mitochondrial dynamic imbalance.
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Background
l-Glutamate, the most abundant excitatory neurotrans-
mitter in the nervous system is involved in a wide variety 
of brain functions and plays a key role in the pathogenesis 
of many neurological disorders. It is a potent neurotoxin 
capable of neuronal destruction when present in high 
concentration. Glutamate-evoked excitotoxicity has been 
implicated in the etiology of many neurodegenerative 
diseases including Alzheimer’s disease (AD), Parkinson’s 
disease (PD), and ischemic stroke [1]. Glutamate-induced 
cell death is mediated in part by overstimulation of the 
postsynaptic glutamate receptor system [2] and non-
receptor mediated oxidative toxicity [3]. Prolonged expo-
sure to high concentrations of extracellular glutamate 
promotes oxidative toxicity by activation of mechanisms 
that negatively impact cysteine uptake into cells via the 
cystine/glutamate antiporter leading to depletion of glu-
tathione (GSH) [3]. Depletion of GSH causes a down-
regulation of the cystine-dependent antioxidant system 
leading to excessive accumulation of reactive oxygen spe-
cies (ROS) accompanied by oxidative stress. Oxidative 
stress perturbs mechanisms that regulate Ca2 + homeo-
stasis in the mitochondria and activates pathways that 
lead to collapse of the mitochondrial membrane polarity 
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and opening of the mitochondrial permeability transition 
pore (MPTP).
Mitochondria are autonomous double membrane-
enclosed organelles present in most mammalian cells, 
and mainly involved in aerobic respiration. They are 
dynamic organelles that continuously undergo remod-
eling by fusion and fission in response to the cellular and 
environmental cues. Mitochondrial fusion and fission 
play critical roles in the maintenance of mitochondrial 
function and regulation of bioenergetic state of the cell. 
Three dynamin-related GTPases, Mitofusins 1 (Mfn1), 
Mitofusin 2 (Mfn2) and optic atrophy 1 (Opa1) are 
required for fusion of the mitochondrial outer and inner 
membranes in mammalian cells [4–6]; while mitochon-
drial fission is mediated by the dynamin-like protein-1 
(Drp1) and the mitochondrial fission 1 protein (Fis1) [7]. 
Mitochondrial fusion results in enlargement of the mito-
chondria through merging of two separate units. In addi-
tion, mitochondrial fusion presumably regulates electron 
transport, mitochondrial metabolism and calcium home-
ostasis [8]. In contrast, mitochondrial fission is essential 
to establish new mitochondria and to eliminate defec-
tive mitochondria by mitochondrial autophagy [9]. Both 
processes are tightly controlled and uniformly balanced 
under physiological conditions.
Autophagy is a vital intracellular catabolic process that 
causes cellular protein and organelle turnover, through 
sequestering and priming proteins for lysosomal deg-
radation [10]. Autophagy can be stimulated by a variety 
of stress-inducing conditions including nutrient deple-
tion, reactive oxygen species, and hypoxia [11]. Activa-
tion of this pathway may not necessarily lead to cell death 
[12]. Defects in the autophagy-regulation and signal-
ing have been associated with many human diseases, 
including neurodegenerative disorders [13]. Three types 
of autophagy (macroautophagy, microautophagy, and 
chaperone-mediated autophagy) have been identified of 
which, microautophagy has been studies extensively [10]. 
A number of key signaling pathways ties autophagy to 
stress responses. Activation of these pathways is orches-
trated by a sequence of core autophagy-related (ATG) 
genes that are evolutionarily conserved. One of the pro-
teins critical to this process is Beclin-1, the mammalian 
orthologue of the yeast autophagy protein Atg6. Beclin-1 
induces autophagy by interacting with several cofactors 
and Vps-34, a class III phosphatidylinositol-3-phosphate 
kinase (PI3kIII/Vps34), to form a complex that pro-
motes autophagosome formation in the early stages of 
autophagy [14]. Unlike Beclin-1, another member of 
the ATG protein family, microtubule-associated pro-
tein 1 light chain 3 (LC3) localize to different autophagic 
membranes and is essential for final autophagosome 
formation. LC3, synthesized as a pro-protein is rapidly 
converted to LC3-I by Atg4 and further transformed by a 
series of conjugating and activating Atg proteins to LC3-
II, the autophagosomal membrane bound form consid-
ered as a marker of autophagy activation.
Selenium is central component at the catalytic sites of 
various selenium-dependent enzymes including Glu-
tathione peroxidase (GPx). Selenium has been demon-
strated to reduce ROS production [15, 16], protect cells 
against glutamate toxicity [17], oxidative stress [18] and 
inflammatory cytokines [19, 20]. Animal experiments 
have showed that selenium supplementation reduces 
ROS production, ameliorates cisplatin induced neuro-
toxicity and ischemia-induced brain damage [21, 22]. 
However, the mechanisms by which selenium exerts its 
protective effect against glutamate insult in neuronal cells 
remains ambiguous. In this study, glutamate exposed 
HT22 cells were used as an in  vitro model to examine 
signaling pathway through which, sodium selenite could 
potentially moderate glutamate-induced toxicity in neu-
ronal cells. Cellular viability, ultrastructural changes, 
ROS production, and biomarkers for autophagy and 
mitochondrial fission were measured respectively. Our 
results showed that sodium selenite blocked glutamate 
provoked neuronal death by restoring mitochondrial 
function, reducing ROS production, inhibiting caspase 
activation, and impairment in autophagy.
Results
Glutamate decreased and selenite increased cell viability
The cell viabilities in vehicle and various concentra-
tions of glutamate treated cells were assessed using 
MTT assay kit after 24  h of incubation (Fig.  1a). The 
results showed that incubation with 2  mM of gluta-
mate reduced the cell viability from 98.8 ± 1.2% in con-
trol to 94.2 ± 0.6% (p > 0.05), while 4 mM of glutamate 
reduced it to 85.2 ± 1.4% (p < 0.01 compared with con-
trol). The cell viability was further decreased with the 
increased concentrations of glutamate. Therefore, the 
cell viabilities were 72.0  ±  1.6% at 6  mM, 54.2  ±  1.6% 
at 8 mM, and 42.5 ±  2.4% at 10 mM of glutamate con-
centrations (p < 0.01 with all three concentrations com-
pared with control). In next experiments, we incubated 
the cell with 6  mM glutamate and 100  nM of sodium 
selenite concurrently and measured cell viability after 
6, 10 and 24 h (Fig. 1b). The results showed that the cell 
viabilities were not significantly altered in selenite, glu-
tamate and glutamate plus selenite groups compared 
with vehicle control after 6 h of incubation. The cell via-
bilities were significantly decreased after 10  h of gluta-
mate incubation to 85.8 ± 2.5% comparing to control of 
100 ± 0.9% (p < 0.01). The viability was further decreased 
to 68.9 ± 3.9% after 24 h of glutamate incubation com-
pared with control (p < 0.01). Compared with glutamate 
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incubation alone, the HT22 cells co-treated with glu-
tamate and selenite had a mild improved cell viability 
after 10  h (92.2 ±  1.3%, p  >  0.05). However, the viabil-
ity was significantly improved by selenite co-treatment 
at 24  h comparing to glutamate alone (83.6  ±  1.5% vs. 
68.9 ± 3.9%, p < 0.01).
Light and electron microscopic findings
Consistent to the results obtained from viability assay, 
cell images captured by inverted light microscope dem-
onstrated normal cell morphology in non-glutamate 
treated control HT22 cells. Glutamate exposure resulted 
in cell shrinkage and nuclear condensation, suggest-
ing cell death (Fig.  2a). Selenite concurrent treatment 
ameliorated glutamate-caused cellular morphological 
changes. Electron microscopic study showed that abun-
dant endoplasmic reticulum (yellow arrow) and mito-
chondria (red arrow), mostly elongated, in the cytosol of 
the control cells. Comparing to the control, mitochondria 
in glutamate-treated cells became lucent and swelling 
(red arrow). In addition, distended rough endoplasmic 
reticulum, abundant presence of lysosomes (blue arrow), 
autophagosomes, and nuclear chromatin margination 
(green arrow) were observed. Selenite concurrent treat-
ment ameliorated glutamate caused alterations in the 
mitochondrion, endoplasmic reticulum and lysosome 
(Fig. 2b).
Selenium decreased glutamate‑induced superoxide 
production
Superoxide productions were measured by DHE fluores-
cent probe following glutamate and/or selenite incuba-
tion. As shown in Fig. 3, faint DHE immunofluorescence 
was detected in normal HT22 control cells, representing 
the basal amount of superoxide (value of 6.0 ± 0.8) pro-
duced during normal cellular metabolic activity. Gluta-
mate exposure resulted in a surge of DHE signal (value 
of 81.0  ±  2.1), suggesting significantly increased super-
oxide production (p < 0.01). Treatment with selenium in 
glutamate-incubated cells reduced the DHE fluorescent 
intensity to 47.0  ±  1.2, a 42% reduction comparing to 
that of non-selenite treated, glutamate exposed cultures 
(p < 0.01).
Glutamate activated and selenium suppressed 
mitochondria‑initiated cell death pathway
Since Apaf-1, caspase-9, and caspase-3 play key roles in 
mediating mitochondria-initiated cell death pathway, 
we performed immunocytochemistry using antibod-
ies against Apaf-1, cleaved caspase-9, and cleaved cas-
pase-3. The results were further verified with Western 
blots using antibodies against Apaf-1, total and cleaved 
caspase-9, and total and cleaved caspase-3. The results 
showed that there were very few faintly stained Apaf-1 
positive neurons in the normal control cells. Glutamate 
exposure for 24  h significantly increased the immuno-
reactivity of Apaf-1 in the cytoplasm as shown in Fig. 4. 
Concurrent treatment with selenite reduced the immu-
noreactivity of Apaf-1 in glutamate-exposed neurons. 
Western blot using cytosolic fraction further support the 
findings showing that Apaf-1 protein band intensity in 
the cytosolic fraction were significantly increased from 
25.3 ± 1.4% in control to 51.8 ± 1.4 in glutamate treated 
cells (p  <  0.01). Selenite treatment significantly reduced 
the Apaf-1 protein band intensity to 32.7 ± 1.4 (p < 0.05 
vs. glutamate treatment).
Similarly, there were very few faintly stained cas-
pase-9 positive cells in control cultures. After glutamate 
Fig. 1 Cell viabilities in three experimental groups assessed by MTT 
assay. a cell viability assays were performed at 24 h of incubation 
with various concentrations of glutamate. The viabilities of the cells 
were reduced to 94.2 ± 0.6, 85.2 ± 1.4, 72.0 ± 1.6, 54.2 ± 1.6, and 
42.5 ± 2.4% with the glutamate at 2, 4, 6, 8, and 10 mM concentra‑
tions. N = 10 in each group. **p < 0.01 versus control by Student’s t 
test. b Cell viability after 6, 10 and 24 h of glutamate (6 mM) incuba‑
tion with or without concurrent addition of selenium (100 nM). After 
10 h of incubation, cell viabilities were reduced to 85.8 ± 2.5% by 
glutamate and the reduction was moderately improved by selenite 
(92.2 ± 1.3%). F(3, 23) = 13.6 and p < 0.001 by ANOVA. After 24 h of 
culture, glutamate further reduced the cell viability to 68.9 ± 3.9%, 
while selenite rescued the viability to 83.6 ± 1.5%. F(3, 23) = 18.9. 
*p < 0.05, **p < 0.01 versus control and ##p < 0.01 versus glutamate by 
ANOVA with post hoc Tukey’s test. Glu glutamate, Se sodium selenite, 
Glu + Se = glutamate + sodium selenite. N = 6 in each group
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treatment for 24  h, the number of caspase-9 positively 
stained neurons increased and concurrent treated of 
selenium decreased immunointensity of caspase-9 
(Fig.  5). The results were further confirmed by Western 
blot. Consistently, glutamate caused significant elevation 
of cleaved caspase-9 (38.4  ±  1.7) compared to control 
(21.8 ± 1.8). Treatment with selenite significantly ablated 
the glutamate-induced increase (27.1 ± 1.1).
There was faint punctuated caspase-3 positive stain-
ing localized in the cytoplasm of non-glutamate-incu-
bated control cells. After glutamate incubation for 24 h, 
caspase-3 immunoreactivity significantly enhanced in 
the cytosol and nuclear translocation was noted. Con-
current treatment with selenite prevented caspase-3 
nuclear translocation but did not seem to reduce the 
immunoreactivity in the cytosol and prevented caspase-3 
nuclear translocation (Fig. 6). Western blot using nuclear 
fraction revealed that cleaved caspase-3 increased sig-
nificantly in glutamate-incubated cells (25.5 ± 1.5) com-
pared with control (13.6  ±  0.8). Such increases were 
ameliorated by selenite treatment (18.7 ± 1.2).
Selenium reduces glutamate‑induced mitochondrial 
fission
Mitochondrial fission markers Fis1, Drp1, and p-Drp1 
were detected in the mitochondrial fraction of the cell 
lysate using Western blotting. As shown in Fig.  7, Pro-
tein band intensity of Fis1 increased significantly in glu-
tamate treated cells (51.1  ±  1.4) comparing to control 
cells (31.4  ±  1.3). Concurrent treatment of glutamate 
Fig. 2 Cell morphology observed by light microscope (a) and electron microscope (b). a Glutamate exposure causes cell shrinkage and nuclear 
condensation. Selenite concurrent treatment reduced glutamate caused cell death. b Glutamate exposure 24 h caused mitochondrial lucency and 
swelling (red arrow), nuclear chromatin margination (green arrow), decreased presence of subcellular organelles, distention of rough endoplasmic 
reticulum (yellow arrow), and increased presence of lysosome (blue arrow). Selenite concurrent treatment reduced glutamate‑caused alterations in 
the mitochdrion, endoplasmic reticulum and lysosome
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incubated cells with selenite significantly reduced the 
level of Fis1 to 40.5 ± 1.3 (p < 0.01). Similarly, glutamate 
increased the p-Drp1 protein relative band intensity from 
12.3 ± 1.1 in control to 32.3 ± 1.4 in glutamate incubated 
cells. Treatment with selenite reduced the p-Drp1 inten-
sity to 16.6 ± 1.0 (p < 0.01). This is further supported by 
the following imaging study.
Selenium suppressed glutamate‑activated autophagy
The last step of autophagy is the fusion of autophago-
some with lysosome. Therefore, colocalization of mito-
chondrial marker MitoTracker Green and lysosomal 
marker LysoTracker Red could be used as an indication of 
mitochondrial autophagy. As shown in Fig. 8, in control 
cells, punctate green staining was observed, represent-
ing normal mitochondria detected by the probe. There 
were almost no lysosomes were detected. After gluta-
mate treatment for 24  h, both MitoTracker Green and 
LysoTracker Red staining increased significantly in the 
cytosol, suggesting increased numbers of mitochondria 
and lysosomes. Treatment with selenite reduced the 
intensity of LysoTracker labeling.
Another marker of autophagy is the conversion of 
LC3-I to LC3-II. LC-3 levels were measure in the cyto-
solic fraction of the cells. It was shown that the levels 
of LC3-II band intensities significantly increased from 
46.8 ± 1.7 in control to 105.4 ± 4.2 in glutamate treated 
cells (p  <  0.01) and selenite reverted the glutamate-
induced elevation back to 57.4 ± 1.8 (p < 0.01).
Discussion
Neuronal cell injury and death are major pathologi-
cal features of many CNS disorders such as Alzheimer’s 
disease, Parkinson’s disease, Huntington’s disease, and 
stroke. These disorders provoke alterations in cell func-
tion and survival in distinct regions of the brain. For 
example, stroke triggers a significant neuronal death and 
several theories, including excitotoxicity, production of 
oxygen free radicals, nitric oxide level, and mitochon-
drial injury have been proposed to explain the cause of 
Fig. 3 Superoxide accumulation measured by dihydroethidium (DHE) fluorescence. Accumulation of superoxide in the cells was measures by incu‑
bation in DHE (red color) after 24 h following glutamate and/or selenium treatments. Cells were counterstained with DAPI to label the nuclei (blue 
color). Relative immunointensity increased from 6.0 ± 0.8 in control to 81.0 ± 2.1 after glutamate exposure. Concurrent treatment of the cells with 
glutamate and selenite reduce the DHE immunointensity to 47.0 ± 1.2. F(2, 23) = 633.5. **p < 0.01 versus control and ##p < 0.01 versus glutamate 
by ANOVA with post hoc Tukey’s test. N = 10 in each group
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damage to neurons during stroke [23, 24]. Ischemic 
stroke occurs as a result of focal cerebral ischemia asso-
ciated with permanent brain infarction. Ischemic stroke 
often leads to excessive glutamate release, acute excito-
toxicity and nerve cell damage. In this study, HT22 cells 
exposed to glutamate was used as in vitro model of stroke 
to explore the effects of selenium on glutamate excitotox-
icity and to assess the underlying mechanisms that lead 
to attenuation of glutamate-induced toxicity in the cell. 
Our findings showed that selenium could attenuate cell 
apoptosis, diminish superoxide production, and decrease 
expression of Apaf-1, caspase 9, and caspase 3. In addi-
tion, selenium decreased the level of the LC-3II, a proxy 
for autophagosome and protected against mitochondrial 
impairment induced by glutamate. Our results further 
indicate that glutamate-induced cell death appears to be 
a results caused by a mechanism that involves structural 
changes typical of apoptosis, including swelling of the 
mitochondria, chromatin condensation, and appearance 
of lysosomes.
Selenium has traditionally been used as a supplement 
for several decades in the prevention and treatment 
Fig. 4 Immunocytochemistry and protein blotting of Apaf‑1. Apaf‑1 (green color) was detected using antibody after 24 h of glutamate or glutamate 
plus selenite treatments. DAPI (blue color) was used to label the nuclei. Western blot was performed using cytosolic fraction. Relative band intensity 
was measured and presented in the bar graph. Β‑tubulin served as internal protein loading control. Glutamate incubation increased the Apaf‑1 
protein band intensity to 51.8 ± 1.4 and concurrent treatment with selenite reduced the value to 32.7 ± 1.4. F(2, 29) = 97.1. *p < 0.05 and **p < 0.01 
versus control; #p < 0.05 versus Glutamate by ANOVA with post hoc Tukey’s test. N = 10 in each group
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of human diseases including Keshan cardiomyopathy 
[25], Kashin-Beck osteoarthropathy [26, 27], osteopenia 
[28] and certain forms of cancers [29–31], and has been 
shown to modulate the functions of a variety of intra-
cellular proteins [32–34]. Recent research has focused 
on the neuroprotective potential of selenium as a can-
didate for therapeutic intervention in hypoxic injuries 
and ischemia-induced neuronal damage [35–39]. The 
neuroprotective effect of selenium may be dependent 
on its antioxidant properties. Selenium in the form of 
selenoprotein is present in the active site of glutathione 
peroxidase and regulates the activity of the enzyme. Glu-
tathione peroxidase participates in the complex antioxi-
dant defense signaling network that is essential for the 
detoxification of cellular stresses induced by free radi-
cals. ROS are chemically reactive molecules that contain 
oxygen such as superoxide, singlet oxygen, and hydrogen 
peroxide (H2O2). They are produced as natural byprod-
ucts of normal metabolism and play beneficial roles in 
cell signaling [40]. However, excessive ROS can be detri-
mental to cells as a result of induction of oxidative stress 
and cellular damage [41]. Earlier studies describing the 
Fig. 5 Immunocytochemistry and protein blotting of caspase‑9. Immunocytochemistry was performed 24 h after treatments using antibody 
against cleaved caspase‑9 (green color) and counterstained with DAPI (blue color). Western blots were performed using antibodies against total and 
cleaved caspase‑9 in the cytosolic fraction. Beta‑tubulin served as an internal control. Relative band intensities were measured and presented in the 
bar graph. Cleaved caspase‑9 protein band intensity increased from 21.8 ± 1.8 in control to 38.4 ± 1.7 after glutamate incubation and reduced to 
27.1 ± 1.1 by selenite treatment. F(2, 29) = 102.4. *p < 0.05, **p < 0.01 versus control; #p < 0.05 versus Glutamate by ANOVA with post hoc Tukey’s 
test. N = 10 in each group
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chronic effect of glutamate exposure in cellular toxic-
ity point to the crucial role of oxidative stress-induced 
ROS as a major stimulus of glutamate-induced cell death 
[17, 42–45]. It has been reported that excessive concen-
trations of extracellular glutamate antagonize the gluta-
mate/cystine-antiporter and inhibit cystine uptake. This 
inhibitory effect leads to accumulation of ROS, oxidative 
stress, and mitochondrial hyperactivation [46]. Previous 
studies have shown that selenium attenuates the level of 
ROS following various in vitro injury models [16, 47–49]. 
Our results are in agreement with these studies. We 
observed high production of cellular superoxide radical 
with glutamate treatment that was considerably reduced 
upon co-treatment with selenium. This suggest that sele-
nium exerts its influence partly by enhancing the activity 
of antioxidant systems in cells under stress.
Apoptosis, also known as programmed cell death, 
is a tightly regulated cell suicide process necessary for 
Fig. 6 Immunocytochemistry and protein blotting of caspase‑3. Immunocytochemistry was performed 24 h after treatments using antibody 
against cleaved caspase‑3 (green color) and counterstained with DAPI (blue color). Western blots were performed using antibodies against cleaved 
caspase‑3 in the nuclear fraction. Beta‑tubulin served as an internal control. Relative band intensities were measured and presented in the bar 
graph. Cleaved caspase‑3 protein band intensity increased from 13.6 ± 0.8 in control to 25.5 ± 1.5 after glutamate incubation and concurrent treat‑
ment of selenite reduced it to 18.7 ± 1.2. F(2, 29) = 67.5. *p < 0.05 and **p < 0.01 versus control; #p < 0.05 versus Glutamate by ANOVA with post 
hoc Tukey’s test. N = 10 in each group
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growth, development, and aging in multicellular organ-
isms. Two well defined apoptotic pathways, intrinsic 
and extrinsic pathways, have been identified. Both path-
ways can be are activated by a variety of physiological 
and pathological conditions or stimuli and converge on 
a common execution point driven by caspases. Caspases 
are a family of cysteine-aspartic proteases endoproteases. 
Caspases are generally divided into two subtypes, initia-
tor and effector caspases. Initiator caspases (caspases-8, 
-9 and -10) contain large prodomains and act as regula-
tors of the caspase proteolytic cascade. Effector caspases 
(caspases-3, -6 and -7) are activated by initiator caspases, 
through proteolytic cleavage, and function in disassem-
bly of cells into apoptotic bodies [50]. Glutamate induces 
cell death through processes that involve both necro-
sis and apoptosis [44, 51] although, apoptosis appears 
to be the major driver of cell fate at late time points. 
Apoptotic process culminate in alterations in the integ-
rity of the inner mitochondrial membrane that results 
in the formation of the MPTP [52], failure of the mito-
chondrial membrane potential and release of pro-apop-
togenic proteins into the cytosol. Among the proteins 
released from the mitochondria is Cytochrome c (Cyt c), 
a major component of the electron transport chain. Cyt 
c binds and activates Apaf-1, recruits procaspase-9 and 
dATP, and thus facilitates assembly of the apoptosome. 
Formation of the multi-protein apoptosome complex 
results in the activation of effector caspases 3, 6, and 7, 
which in turn translocates to the nucleus, and initiates 
cleavage of DNA and subsequent degradation of nucle-
osomal proteins [53]. Our findings show that the mag-
nitude of Apaf-1, increased significantly in HT-22 cells 
under glutamate tension, while selenium antagonized 
the glutamate-induced increase in Apaf-1. Furthermore, 
glutamate-dependent increase in Apaf-1 was accompa-
nied by concomitant increases in cleaved caspase 9 and 
cleaved caspase 3. Our data indicate that selenium also 
reduced the stimulation of caspase 9 and caspase-3-like 
Fig. 7 Western blotting of mitochondrial fission proteins. Fission proteins Fis‑1, total Drp‑1 and phospho‑Drp1 (p‑Drp1) were semi‑quantified in the 
mitochondrial fractions using specific antibodies. COX IV served as an internal control. Band relative densities were measured and presented in the 
bar graphs. Fis‑1 protein band intensity increased from 31.4 ± 1.3 in control to 51.1 ± 1.4 after glutamate incubation and reduced back to 40.5 ± 1.3 
by selenite. F(2, 29) = 24.2. *p < 0.05 and **p < 0.01 versus control; #p < 0.05 and ##p < 0.01 versus Glutamate by ANOVA host hoc Tukey’s test. 
Similarly, p‑Drp‑1 ban intensity increased from 12.3 ± 1.1 in control to 32.3 ± 1.4 in glutamate and declined to 16.6 ± 1.0 in selenite and glutamate 
co‑treated cells. F(2, 29) = 54.7. *p < 0.05 and **p < 0.01 versus control; #p < 0.05 and ##p < 0.01 versus Glutamate by ANOVA with post hoc Tukey’s 
test. N = 10 in each group
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protease activity that occurs in glutamate exposed cells. 
These selenium-dependent influences on effector cas-
pase have been demonstrated previously in other cellu-
lar and in vivo animal models [15, 16, 54]. Apaf-1 is one 
of the well-studied physiological regulator of events of 
mitochondria-dependent apoptosis in most death path-
ways. Typically, it exists in an auto-inhibited form in the 
cytosol until it binds to Cyt c and promotes assembly of 
the apoptosome [55]. Our present findings suggest that 
inhibition of Apaf-1 activity may play a central role as a 
potential mechanism by which selenium protects HT22 
cells from glutamate excitotoxicity.
The structure of mitochondria is mainly regulated 
by cycles of fusion and fission. During apoptosis, mito-
chondria undergo fission, chromatin condensation, and 
becomes highly fragmented [56]. The mammalian Drp1 
is a dynamin-related cytoplasmic GTPase that mediates 
mitochondrial fission. Drp1 is a highly regulated protein 
and undergoes a number of steps including transloca-
tion from cytoplasm to the mitochondrial outer mem-
brane for fission to occur [57, 58]. Our results showed 
that p-Drp1, as well as Fis-1, increased significantly after 
glutamate exposure, suggesting that glutamate triggered 
mitochondrial fission. Selenium treatment hampered 
Fig. 8 Co‑localization of MitoTracker Green and LysoTracker Red. The cells were incubated for 30 min with MitoTracker Green (green color) and 
LysoTracker Red (red color) to visualize the colocalization of mitochondria and lysosomes. Colocalization of the two dyes turns the color into orange. 
Western blot detected LC3‑I and II in the mitochondrial fraction. Relative LC3‑II band intensities were measured and presented in the bar graph. LC3‑
II protein band intensity increased from 46.8 ± 1.7 in control to 105.4 ± 4.2 in glutamate and reduced to 57.4 ± 1.8 in selenite treated groups. F(2, 
29) = 124.9. *p < 0.05 and **p < 0.01 versus control; ##p < 0.01 versus glutamate by ANOVA with post hoc Tukey’s test. N = 10 in each group
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the increases of p-Drp1 and Fis-1, indicating its ability 
of preventing mitochondrial fission. It is widely accepted 
that fragmentation associated with mitochondrial fis-
sion is a key activator of mitochondrial autophagy. Dur-
ing autophagy, components of damaged mitochondria 
are encapsulated in autophagosomes. Progression of 
autophagy is dependent on the recruitment of LC3-II, a 
c-terminal lipidated form of cytosolic LC3-I as a struc-
tural component of the autophagosomal membrane. 
Thereafter, LC3-II tagged autophagosomes are deliv-
ered to the lysosome/vacuole for degradation by lyso-
somal hydrolases. Our results revealed that glutamate 
increased the presence of lysosome in the cytoplasm and 
colocalization with the mitochondrial marker, support-
ing the prediction that glutamate induces mitochondrial 
autophagy. The presence of autophagy was supported 
by quantifying the relationship between LC3-I and LC3-
II. Glutamate exposure led to an increase in autophagy 
as reflected in the conversion of LC3-I to LC3-II using 
Western blotting. Selenium on the other hand, signifi-
cantly reduced the intensity of LysoTracker labeling and 
blocked the alteration of LC3-I to LC3-II, and thus, pro-
tected against glutamate-dependent cell death. Increased 
levels of Beclin 1 and upregulation of LC3-II relative to 
LC3-I as markers of autophagy in cells exposed to glu-
tamate have been reported in our earlier studies [17]. 
Although the mechanisms by which selenium altered the 
ratios of LC3-I and LC3-II in the presence of glutamate 
is uncertain, we posit that selenium could modulate this 
process potentially by blocking the upstream conjuga-
tion of phosphatidylethanolamine to LC3-I, or enable 
interconversion of LC3-II back to LC3-I. The actual 
mechanism(s) remains to be elucidated.
Conclusions
Our results indicate that glutamate exposure causes 
increase of superoxide radical, activation of mitochon-
dria-initiated cell death pathway, tilting mitochondrial 
dynamic balance towards fission and triggers mitochon-
drial autophagy. Concurrent treatment with sodium sel-
enite rescues glutamate-induced cell death by reducing 
superoxide production, inhibiting intrinsic cell death 
pathway, blocking mitochondrial fission and suppressing 
mitochondrial autophagy. It is concluded that the protec-
tive effects of selenium against glutamate cytotoxicity is 




Murine hippocampal neuronal HT22 cells (originally pur-
chased from ATCC) were cultured in Dulbecco’s Modi-
fied Eagle Medium (DMEM)/F12 (Invitrogen, Carlsbad, 
CA), supplemented with 10% fetal bovine serum (FBS, 
HyClone), 100 nM penicillin/streptomycin, at 37 °C in 5% 
CO2 and 90% relative humidity. The culture medium was 
renewed every 2  days. Sodium glutamate, and sodium 
selenite (Sigma-Aldrich, St Lois, MO), were reconstituted 
in water and diluted to appropriate concentrations in cell 
culture medium. Antibodies directed against caspase-3, 
caspase-9, apoptosis protease-activating factor-1 (Apaf-
1), cleaved caspase-3, cleaved caspase-9 were purchased 
from Cell Signaling Technology, Danvers, MA. Anti 
LC3A/B, Fis1, Drp1, p-Drp1, and β-actin were purchased 
from Abcam, Cambridge, MA.
Cell viability assay
Cell viability was assessed with MTT cell proliferation 
assay kit (Trevigen Inc., Gaithersburg, MD) accord-
ing to manufacturer’s instructions. In brief, HT22 cells 
were plated into 96-well plates (5000/well, Corning Inc., 
New York, NY). After seeding 24 h the cultures exposed 
to various concentrations of glutamate (2, 4, 6, 8, and 
10 mM). After 24 h of incubation, the results were read 
in the SpectraMax microplate reader (Molecular Devices, 
Sunnyvale, CA). Glutamate of 6 mM was selected for the 
subsequent experiments.
Selenium treatment
Sodium selenite (100 nM) was added to the media con-
currently with the glutamate. The selection of selenium 
concentration was based on results of previous publica-
tions [17, 23], which showed that 100–200 nM selenium 
provided the adequate neuroprotection in  vitro, while 
500 nM was toxic to the cells.
Electron microscopy
Log-phase cultures were collected, centrifuged and the 
pellets were fixed with 2% glutaraldehyde solution for 2 h 
at 4 °C. The samples were incubated in osmic acid for 2 h 
and 0.1 M dimethyl sodium arsenate buffer for 15 min for 
2 times at 4 °C. Thereafter, the pellets were dehydrated in 
ascending ethanol, rinsed in propylene oxide, and incu-
bated in propylene oxide and resin before embedding 
resin. The pellets were sliced and imaged on a transmis-
sion electron microscope.
Determination of superoxide radical
Superoxide anion production was measured by dihydro-
ethidine (DHE) in glutamate only or selenium-co-treated 
HT22 cells exposed to glutamate (6  mM). Briefly, cells 
(5000 per well) were seeded on glass slides. After 24  h 
treatment period, the slides were incubated with the DHE 
(50 μM) for 45 min at 37 °C, washed with PBS, and fixed 
in 4% paraformaldehyde. Images were captured under 
400× magnification using a fluorescent microscope 
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(Olympus CHC-212) and fluorescent intensity was meas-
ured by IPP6.0 software.
Western blotting
For immunoblotting, treated cells were lysed in RIPA 
buffer containing protease (Roche Diagnostics Corp., 
Indianapolis, IN) and phosphatase (ThermoFisher Scien-
tific, Waltham, MA) inhibitor cocktails.
The cells were lysed and subcellular fractions of the 
cytosol, mitochondrion, and nucleus were isolated 
through various peed of centrifugations [17]. Twenty 
micrograms of proteins in the total cell lysates were sepa-
rated on 4–12% NuPAGE SDS-PAGE gels (Invitrogen), 
transferred to nitrocellulose membrane, and probed with 
the following antibodies:anti-Apaf-1 (1:500) and anti-
caspase-9 (1:1000) for the cytosolic fraction; anti-cas-
pase-3 (1:500) for the nuclear fraction; and anti-LC3A/B 
(1:1000), Fis 1 (1:2000), Drp1 (1:2000), p-Drp1 (1:1000) 
for the mitochondrial fraction. Anti β-actin (1:1000) was 
used as internal control for protein loading. After wash-
ing, the membranes were incubated in HRP-conjugated 
secondary anti IgG (1:5000) for 3 h at room temperature. 
Antibody binding was detected by enhanced chemilu-
minescence using Gel imaging analyzer (BIO-Rad Inc., 
Hercules, CA) and band intensity was measured using 
Image-J2x software.
Immunofluorescence
Cells were seeded for 24  h on glass slides and treated 
with glutamate or glutamate and selenium for additional 
24 h in a humidified incubator at 37 °C and 5% CO2. The 
slides were washed with PBS, fixed with 4% paraform-
aldehyde for 15  min and permeabilized with 1% Tri-
tonX-100 for 30 min. The nonspecific binding sites were 
blocked with 10% goat serum and incubated overnight 
at 4  °C with antibodies against Apaf-1 (1:100), cleaved 
caspase-3 (1:100), and cleaved caspase-9 (1:100). After 
washing 3 times in PBS the slides were incubated second-
ary antibody (1:200) for 1 h at 4 °C and DAPI for 5 min in 
a dark environment. Images were captured in each well 
at a magnification of 400× and fluorescence intensities 
were measured as describe previously.
Detection of autophagy
Autophagy was detected by immunofluorescent double 
labeling with LysoTracker Red and MitoTracker Green. 
Cells were seeded in 12-well plate and treated with glu-
tamate and selenium as previously described. Following 
treatment, LysoTracker Red (75  nM), was added to the 
culture medium and the cells were returned to the incu-
bator for 45 min. MitoTracker Green (100 nM) was then 
added into culture medium an incubation continued for 
additional 45 min in a humidified incubator at 37 °C and 
5% CO2. The slides were washed with PBS and fixed with 
4% paraformaldehyde. Images were captured under the 
magnification of 400× using a fluorescent microscope 
(Olympus CHC-212) and fluorescent intensity were 
measured by IPP6.0 software.
Statistics
All experiments were repeated at least 2 times and car-
ried out in triplicate. Statistical analysis was performed 
with IBM SPSS Statistics 19.0. All values were expressed 
as mean ±  SEM. Data in Fig.  1a were analyzed by Stu-
dent’s t test. Data in Figs. 1b and 3, 4, 5, 6, 7 and 8 were 
analyzed by one-way ANOVA and followed by Tukey’s 
test to detect differences between groups. Statistical sig-
nificance was set at p < 0.05.
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